- Home
- ZLAB vs HAYW Comparison
ZLAB vs HAYW Comparison
Compare ZLAB & HAYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ZLAB
- HAYW
- Stock Information
- Founded
- ZLAB 2013
- HAYW 1925
- Country
- ZLAB China
- HAYW United States
- Employees
- ZLAB N/A
- HAYW N/A
- Industry
- ZLAB Biotechnology: Pharmaceutical Preparations
- HAYW Electronic Components
- Sector
- ZLAB Health Care
- HAYW Technology
- Exchange
- ZLAB Nasdaq
- HAYW Nasdaq
- Market Cap
- ZLAB 3.0B
- HAYW 3.5B
- IPO Year
- ZLAB 2017
- HAYW 2021
- Fundamental
- Price
- ZLAB $26.05
- HAYW $15.11
- Analyst Decision
- ZLAB Strong Buy
- HAYW Hold
- Analyst Count
- ZLAB 3
- HAYW 4
- Target Price
- ZLAB $55.00
- HAYW $17.33
- AVG Volume (30 Days)
- ZLAB 482.4K
- HAYW 1.7M
- Earning Date
- ZLAB 02-25-2025
- HAYW 02-27-2025
- Dividend Yield
- ZLAB N/A
- HAYW N/A
- EPS Growth
- ZLAB N/A
- HAYW 40.94
- EPS
- ZLAB N/A
- HAYW 0.43
- Revenue
- ZLAB $355,748,000.00
- HAYW $1,003,000,000.00
- Revenue This Year
- ZLAB $49.04
- HAYW $5.40
- Revenue Next Year
- ZLAB $46.70
- HAYW $6.98
- P/E Ratio
- ZLAB N/A
- HAYW $35.12
- Revenue Growth
- ZLAB 35.01
- HAYW 3.09
- 52 Week Low
- ZLAB $13.48
- HAYW $11.96
- 52 Week High
- ZLAB $36.60
- HAYW $16.87
- Technical
- Relative Strength Index (RSI)
- ZLAB 50.14
- HAYW 47.87
- Support Level
- ZLAB $23.82
- HAYW $14.58
- Resistance Level
- ZLAB $25.64
- HAYW $15.51
- Average True Range (ATR)
- ZLAB 1.24
- HAYW 0.29
- MACD
- ZLAB 0.06
- HAYW 0.01
- Stochastic Oscillator
- ZLAB 64.45
- HAYW 64.87
About ZLAB Zai Lab Limited
Zai Lab Ltd is a biopharmaceutical company focusing on discovering or licensing, developing, and commercializing proprietary therapeutics that address areas of unmet medical need including in the fields of oncology, autoimmune and infectious diseases. The pipeline of proprietary drug candidates of the company includes ZL-2306 for treatments across multiple solid tumor types including ovarian and certain types of breast and lung cancers; ZL-2401 which is an antibiotic in a new class of tetracycline derivatives; and ZL-2301 is an oral, small molecule which targets HCC.
About HAYW Hayward Holdings Inc.
Hayward Holdings is a leading manufacturer of energy-efficient swimming pool equipment and pool automation systems. The company offers a wide range of pool equipment, including pumps, filters, heaters, LED lights, and sanitization. Headquartered in Charlotte, North Carolina, the company has around 2,000 full-time employees. Hayward generated approximately $1.0 billion in revenue in 2023.